Navigation Links
Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
Date:3/10/2008

Preclinical Studies Demonstrate a Viable Intravenous Inosine Formulation

and Support Oral Dosing for Three Alseres' DAT Blocker Compounds

HOPKINTON, Mass., March 10 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) announced that data from preclinical studies of the Company's nerve repair candidate, Inosine, and DAT Blocker product candidates from its neurodegeneration program were presented at the ASENT conference, March 6-8, 2008 in Arlington, VA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

The first poster presentation entitled: "Brain microdialysate and plasma concentrations of Inosine during intravenous Inosine infusion in conscious rats" highlighted the results of a central nervous system (CNS) microdialysis study designed to measure the levels of Inosine in the brain during intravenous infusion of high concentrations of Inosine. The results suggest that Inosine infused intravenously was measurably able to cross the blood- brain barrier. Inosine is a nerve regenerative factor that has been shown to promote axon outgrowth in neurons and has potential to be used to treat CNS disorders such as stroke, spinal cord injury and traumatic brain injury.

"The literature suggests that Inosine can cross the blood-brain barrier, however, no direct measurements of brain levels of Inosine during systemic dosing have been previously reported," commented Noel Cusack, Ph.D, Alseres' Senior Vice President of Preclinical Development. "This study shows that when administered intravenously using our new, highly-concentrated Inosine formulation, Inosine levels in the brain increased more than 600%,
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
2. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
3. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
5. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
6. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
7. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
8. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
9. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
(Date:12/24/2014)... Island, New York (PRWEB) December 23, 2014 ... and the Long Island Affiliate of ITRA Global, the national ... slow but steady recovery. This is evidenced by the ... the strong stock market. Low energy costs have held ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... -- I continue to be encouraged by the numerous ... Midwest. Here are just a few: , ,& bull; The ... 2006. , ,& bull; The continued acquisition of Midwest ... recognize the value of Midwest products and technology, the flip ...
... in Memphis, Tenn., will install a wireless distribution ... organization's corporate office under a $6 million agreement with ... distribution system will provide wireless coverage throughout Baptist's six ... system, which will be installed in the next 12 ...
... a biophysical chemist at the University of Wisconsin-Madison, has ... the Biophysical Society, a 7,000-member U.S. organization that represents ... and biochemistry, Record hopes that the new honor will ... funding for his research. , ,A UW-Madison faculty member ...
Cached Biology Technology:Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4
(Date:1/22/2015)... 22, 2015 Research and Markets ( ... "Global Wearable Technologies Market and Applications, Opportunities, ... and Forecast 2014-2020" report to their offering. ... devices that can be worn on the user,s ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, ... to eliminate the pain of trying to remember their usernames ... biometrics fused to their smartphones. To assist people who have ... the company that created 1U and focuses on redefining identity, ...
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday Season ... as Acuity Market Intelligence reports that the long anticipated ... forecasts that intensifying demand for smart phones, tablets, and ... global market of 2.5 billion users with nearly 4.8 ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... as well known for keeping us healthy as it is ... a new research report appearing in the March 2010 print ... scientists explain how they developed a genetically modified strain of ... scum, scientifically known as microcystin-LR (MC-LR), which makes water unsafe ...
... silkworm moths, butterflies and spiders, caddisfly larvae spin silk, but ... of Utah researchers have discovered why the fly,s silk is ... as an adhesive tape during surgery. "Silk from caddisfly ... may be useful some day as a medical bioadhesive ...
... of business for any fledgling plant embryo is to determine which ... researchers at the Salk Institute expose the turf wars between two ... polar axis with a root on one end and a shoot ... important decision for a plant, setting up the root/shoot axis, occurs ...
Cached Biology News:Glue, fly, glue 2Glue, fly, glue 3Glue, fly, glue 4Glue, fly, glue 5Root or shoot 2Root or shoot 3
... Engine Dyad instrument is the most advanced ... MJ's world-class thermal performance, the Dyad also ... well as point-and-click navigation via touch pad ... be easily and economically expanded to a ...
...
...
... instrument is the most advanced thermal cycler ... thermal performance, the Dyad also boasts graphical ... point-and-click navigation via touch pad or mouse. ... and economically expanded to a four-bay system ...
Biology Products: